Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes
Stefano Ciardullo, Gianluca Perseghin
Metabolism (2021) Vol. 121, pp. 154752-154752
Closed Access | Times Cited: 81

Showing 26-50 of 81 citing articles:

Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex
Yasuhiro Matsubayashi, Kazuya Fujihara, MAYUKO H. YAMADA, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 27
The association between non‐alcoholic fatty liver disease and serum ferritin levels in American adults
Naibin Yang, Yi Lu, Cao Liwen, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 2
Open Access | Times Cited: 25
Nonsteroidal Anti-Inflammatory Drugs and Oral Corticosteroids Mitigated the Risk of Arthrofibrosis After Total Knee Arthroplasty
Harold I. Salmons, Ashley N. Payne, Michael J. Taunton, et al.
The Journal of Arthroplasty (2023) Vol. 38, Iss. 6, pp. S350-S354
Open Access | Times Cited: 13
Correlation between ratio of fasting blood glucose to high density lipoprotein cholesterol in serum and non-alcoholic fatty liver disease in American adults: a population based analysis
Xianjing Jin, Jing Xu, Xiaochun Weng
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 5
Association Between Monocyte to High-Density Lipoprotein Cholesterol Ratio and Risk of Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study
Liping Wang, Jin‐Zhong Dong, Miao Xu, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 21
Risk of liver fibrosis in patients with prediabetes and diabetes mellitus
Jongsin Park, Heon‐Ju Kwon, Won Sohn, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0269070-e0269070
Open Access | Times Cited: 19
The key role of inflammation in the pathogenesis and management of obesity and CVD
Chrysoula Boutari, Michael A. Hill, Claudio Procaccini, et al.
Metabolism (2023) Vol. 145, pp. 155627-155627
Closed Access | Times Cited: 11
Anti-fibrotic effects of statin drugs: A review of evidence and mechanisms
David Dolivo, Charlotte R. Reed, Kristine A. Gargiulo, et al.
Biochemical Pharmacology (2023) Vol. 214, pp. 115644-115644
Closed Access | Times Cited: 11
Protective effects of statins on the incidence of NAFLD–related decompensated cirrhosis in T2DM
Szu‐Yuan Wu, Wan‐Ming Chen, Ming‐Feng Chiang, et al.
Liver International (2023) Vol. 43, Iss. 10, pp. 2232-2244
Closed Access | Times Cited: 11
Differential Association of Sex Hormones with Metabolic Parameters and Body Composition in Men and Women from the United States
Stefano Ciardullo, Francesca Zerbini, Rosa Cannistraci, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4783-4783
Open Access | Times Cited: 11
Association between body roundness index and risk of ultrasound-defined non-alcoholic fatty liver disease
Enfa Zhao, Xiaolin Wen, Wenqian Qiu, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23429-e23429
Open Access | Times Cited: 11
Association of composite dietary antioxidant index and muscle mass in individuals with metabolic associated fatty liver disease
Jing Guo, Lin Shi, Yan Sun
Clinics and Research in Hepatology and Gastroenterology (2024) Vol. 48, Iss. 2, pp. 102284-102284
Closed Access | Times Cited: 4
The association of triglyceride-glucose-waist circumference with metabolic associated fatty liver disease and the severity of liver steatosis and fibrosis in American adults: a population-based study
Zhouxiao Wu, Kai Huang, Sizeng Bao, et al.
Scandinavian Journal of Gastroenterology (2024) Vol. 59, Iss. 5, pp. 561-569
Closed Access | Times Cited: 4
A late eating midpoint is associated with increased risk of diabetic kidney disease: a cross-sectional study based on NHANES 2013–2020
Chunfeng Lu, Xiaomin Cang, Wangshu Liu, et al.
Nutrition Journal (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Association between cardiometabolic index and hepatic steatosis and liver fibrosis: a population-based study
Lulu Cheng, Qinggang Wu, Siyu Wang
HORMONES (2024)
Closed Access | Times Cited: 4
Association between triglyceride to high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease and liver fibrosis in American adults: an observational study from the National Health and Nutrition Examination Survey 2017–2020
Jianjun Wang, Han Li, Xiaoyi Wang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 4
Elevated GGT to HDL ratio as a marker for the risk of NAFLD and liver fibrosis
Yanyan Xuan, Fang-Fang He, Qing Liu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Non‑high‑density lipoprotein cholesterol to high‑density lipoprotein cholesterol ratio as a biomarker for liver health: Insights from National Health and Nutrition Examination Survey data
Liekai Hong, Yi‐Fan Sun, Xiaojia Lu, et al.
Biomedical Reports (2025) Vol. 22, Iss. 4
Open Access
Association between the NHHR and hepatic steatosis and liver fibrosis: a population-based study
Xiaoxian Yang, Yan Han, Rui Guo, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Association of platelet to albumin ratio with metabolic dysfunction-associated steatotic liver disease based on the National Health and Nutrition Survey 2017–2018
Jinbo Xie, Qingliu He, David Fisher, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Correlation between hs-CRP-triglyceride glucose index and NAFLD and liver fibrosis
Yuhui Zhou, Hao Lin, Xiaochun Weng, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Mortality among individuals with chronic kidney disease based on the 2012 and 2021 KDIGO blood pressure targets
Sijue Zou, Yan Zhang, Xin He, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Associations of Uric Acid With Liver Steatosis and Fibrosis Applying Vibration Controlled Transient Elastography in the United States: A Nationwide Cross-Section Study
Hualin Duan, Rong Zhang, Xingying Chen, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 18
Association between antidepressant use and liver fibrosis in patients with type 2 diabetes: a population based study
Lin Shi, Fangyuan Jia
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Correlation between ZJU index and hepatic steatosis and liver fibrosis in American adults with NAFLD
Shuang Luo, Xiaolu Weng, Jing Xu, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3

Scroll to top